Member access

4-Traders Homepage  >  Shares  >  NASDAQ OMX NORDIC  >  Meda AB    MEDAA   SE0000221723

MEDA AB

 (MEDAA)
0
Delayed Quote. Delayed BATS Europe - 05/23 04:56:10 am
80.6 SEK   -1.53%
05/08 MEDA AB: ex-dividend day for annual dividend
05/07 MEDA AB: (publ) AGM bulletin
05/07 MEDA AB: Interim Report, January–March 2013
SummaryNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Income Statement Evolution
Meda AB : Income Statement Evolution
Annual Income Statement Data
Actuals in M SEK Estimates in M SEK
Fiscal Period December 201020112012201320142015
Sales11 57112 85612 99113 08913 78514 542
Operating income (EBITDA)4 3064 6833 9353 9184 4294 939
Operating profit (EBIT)2 5292 6441 7911 7222 2092 757
Pre-Tax Profit (EBT)1 9772 0401 2431 2081 7982 546
Net income1 4441 6161 2099741 4362 028
EPS ( SEK)4,725,324,003,284,666,24
Dividend per Share ( SEK)2,002,252,252,232,643,14
Yield2,44%2,75%2,75%2,73%3,23%3,83%
Announcement Date02/14/2011
07:00am		02/17/2012
07:00am		02/19/2013
07:00am		---
Finances - Leverage
Meda AB : Finances - Leverage
Actuals in M SEK Estimates in M SEK
Fiscal Period December 201020112012201320142015
Debt13 52417 36115 44913 73511 6829 311
Finance------
Operating income (EBITDA)4 3064 6833 9353 9184 4294 939
Leverage
(Debt/EBITDA)		3,14x3,71x3,93x3,51x2,64x1,89x
Capital Expenditure-4 115126227239223
Book Value Per Share (BVPS)46,1  SEK49,5  SEK50,0  SEK50,9  SEK53,5  SEK57,5  SEK
Cash Flow per Share8,39  SEK9,07  SEK9,31  SEK10,2  SEK11,7  SEK13,3  SEK
Announcement Date02/14/2011
07:00am		02/17/2012
07:00am		02/19/2013
07:00am		---
Balance Sheet Analysis
Meda AB : Balance Sheet Analysis
Assessed data source :
© 2013 Thomson Reuters
Advertisement
Financial Ratios

Size 2013e 2014e
Capitalization 24 851 M SEK -
Company Value 38 587 M SEK 36 534 M SEK
Valuation 2013e 2014e
PER (Price / EPS) 25,0x 17,6x
Capitalization / Revenue 1,90x 1,80x
EV / Revenue 2,95x 2,65x
EV / EBITDA 9,85x 8,25x
Yield (DPS / Price) 2,73% 3,23%
Profitability 2013e 2014e
Operating Margin (EBIT / Sales) 13,2% 16,0%
operating laverage (Delta EBIT / Delta Sales) - 5,31x
Net Margin (Net Profit / Revenue) 7,44% 10,4%
ROA (Net Profit / Asset) 4,70% 5,80%
ROE (Net Profit / Equities) 8,26% 8,79%
Rate of Dividend 68,0% 56,7%
Balance Sheet Analysis 2013e 2014e
CAPEX / Sales   1,73% 1,73%
Cash Flow / Sales (Taux d'autofinancement) 23,6% 25,6%
Capital Intensity (Assets / Sales) 1,58x 1,80x
Financial Leverage (Net Debt / EBITDA) 3,51x 2,64x
Price Earning Ratio
Meda AB : Price Earning Ratio
EPS & Dividend
Meda AB : EPS Dividend
Dynamic quotes  
ON
| OFF
My Watchlist|My Portfolio
4-traders.com :
About :
Copyright © 2013 Surperformance. All rights reserved.